Nilutamide
Nilandron
Androgen Receptor Inhibitor
NADAC/unit
N/A
No Shortage
Tier 1: 18.5%
PA Req: 11.2%
1 Manufacturers
1 ANDAs
Active Shortages
2025-12-01 Product to expire in March 2026; Discontinuation of the manufacture of the drug, Advanz Pharma (US) Corp.
2025-12-01 Product to expire in March 2026; Discontinuation of the manufacture of the drug, Advanz Pharma (US) Corp.
Generic Manufacturers
ADVANZ PHARMA (US) CORPANI PHARMACEUTICALS INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.